ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
30.50
+0.15 (0.49%)
Jun 8, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.42 billion as of June 8, 2026. Its market cap has increased by 101.26% in one year.
Market Cap
1.42B
Enterprise Value
1.09B
1-Year Change
101.26%
Ranking
Category
Stock Price
$30.50
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.42B, an increase of 146.96%. That is a compound annual growth rate of 46.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 1.42B | 71.03% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 1.47B |
| AnaptysBio | 1.47B |
| Vir Biotechnology | 1.46B |
| AtaiBeckley | 1.45B |
| MBX Biosciences | 1.44B |
| Immunocore Holdings | 1.44B |
| KalVista Pharmaceuticals | 1.43B |
| Septerna | 1.40B |